Fertility Preservation in Hypogonadal Men

[1]  K. Flegal,et al.  Comparisons of Self‐Reported and Measured Height and Weight, BMI, and Obesity Prevalence from National Surveys: 1999‐2016 , 2019, Obesity.

[2]  Ross W. Ormsby,et al.  Efficacy of Nasal Testosterone Gel (Natesto®) Stratified by Baseline Endogenous Testosterone Levels , 2019, Journal of the Endocrine Society.

[3]  N. Pendleton,et al.  Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS , 2018, Clinical endocrinology.

[4]  I. Goldstein,et al.  PRESERVATION OF NORMAL CONCENTRATIONS OF PITUITARY GONADOTROPINS DESPITE ACHIEVEMENT OF NORMAL SERUM TESTOTERONE LEVELS IN HYPOGONADAL MEN TREATED WITH A 4.5% NASAL TESTOSTERONE GEL: MP89‐06 , 2017 .

[5]  D. Freeborn,et al.  Comparison of Testosterone Replacement Therapy Medications in the Treatment of Hypogonadism , 2017 .

[6]  H. Dandapantula,et al.  State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males , 2017, Current Cardiology Reports.

[7]  J. B. Layton,et al.  Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013 , 2017, JAMA.

[8]  N. Santoro,et al.  Acute Recapitulation of the Hyperinsulinemia and Hyperlipidemia characteristic of Metabolic Syndrome suppresses Gonadotropins , 2016, Obesity.

[9]  A. Presson,et al.  Characterising the safety of clomiphene citrate in male patients through prostate‐specific antigen, haematocrit, and testosterone levels , 2016, BJU international.

[10]  Edward D. Kim,et al.  Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement , 2016, BJU international.

[11]  A. Rogol,et al.  Natesto™, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men , 2016, Andrology.

[12]  D. Lamb,et al.  Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen , 2015, Sexual medicine.

[13]  D. Lamb,et al.  The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. , 2015, The journal of sexual medicine.

[14]  M. Rutter,et al.  Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. , 2015, The Journal of clinical endocrinology and metabolism.

[15]  R. Hamman,et al.  The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions , 2014, Diabetes Care.

[16]  L. Lipshultz,et al.  Preserving fertility in the hypogonadal patient: an update , 2014, Asian journal of andrology.

[17]  L. Lipshultz,et al.  Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. , 2014, Fertility and sterility.

[18]  C. Nelson,et al.  Predicting biochemical response to clomiphene citrate in men with hypogonadism. , 2014, The journal of sexual medicine.

[19]  L. Lipshultz,et al.  Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. , 2014, The Journal of urology.

[20]  R. Swerdloff,et al.  An update on male hypogonadism therapy , 2014, Expert opinion on pharmacotherapy.

[21]  B. Dofitas,et al.  Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta‐analysis , 2013, Andrology.

[22]  J. Goodwin,et al.  Trends in androgen prescribing in the United States, 2001 to 2011. , 2013, JAMA internal medicine.

[23]  D. Lamb,et al.  The effects of advanced paternal age on fertility. , 2013, Asian journal of andrology.

[24]  A. Araujo,et al.  Longitudinal changes in testosterone over five years in community-dwelling men. , 2013, The Journal of clinical endocrinology and metabolism.

[25]  G. Fontenot,et al.  Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. , 2013, The journal of sexual medicine.

[26]  C. Niederberger,et al.  Optimization of spermatogenesis‐regulating hormones in patients with non‐obstructive azoospermia and its impact on sperm retrieval: a multicentre study , 2013, BJU international.

[27]  L. Lipshultz,et al.  Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. , 2013, The Journal of urology.

[28]  P. Schlegel,et al.  Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia. , 2012, The Journal of urology.

[29]  J. Mulhall,et al.  Outcomes of clomiphene citrate treatment in young hypogonadal men , 2012, BJU international.

[30]  P. Bakas,et al.  Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. , 2012, Fertility and sterility.

[31]  Edmund Y Ko,et al.  Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association. , 2012, The Journal of urology.

[32]  K. Shiraishi,et al.  Human chorionic gonadotrophin treatment prior to microdissection testicular sperm extraction in non-obstructive azoospermia. , 2012, Human reproduction.

[33]  Vasan Sathya Srini,et al.  Does Varicocelectomy Improve Gonadal Function in Men with Hypogonadism and Infertility? Analysis of a Prospective Study , 2011, International journal of endocrinology.

[34]  C. Foresta,et al.  The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. , 2011, International journal of andrology.

[35]  O. Efesoy,et al.  The effect of aromatase inhibitor letrozole on body mass index, serum hormones, and sperm parameters in infertile men. , 2011, Fertility and sterility.

[36]  A. Hoffman,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[37]  A. Agarwal,et al.  Increased levels of oxidants and reduced antioxidants in semen of infertile men with varicocele. , 2010, Fertility and sterility.

[38]  H. Ghanem,et al.  Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. , 2010, Fertility and sterility.

[39]  Z. Rosenwaks,et al.  Successful fertility treatment for Klinefelter's syndrome. , 2009, The Journal of urology.

[40]  C. Howles,et al.  A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. , 2009, Fertility and sterility.

[41]  S. Song,et al.  Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. , 2009, The Journal of clinical endocrinology and metabolism.

[42]  R. Sokol.  Endocrinology of male infertility: evaluation and treatment. , 2009, Seminars in reproductive medicine.

[43]  J. Amory,et al.  Treatment of male infertility secondary to morbid obesity , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[44]  A. Rane,et al.  Use of doping agents, particularly anabolic steroids, in sports and society , 2008, The Lancet.

[45]  A. Agarwal,et al.  Efficacy of varicocelectomy in improving semen parameters: new meta-analytical approach. , 2007, Urology.

[46]  S. Bhasin.  Approach to the infertile man. , 2007, The Journal of clinical endocrinology and metabolism.

[47]  G. Balercia,et al.  Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. , 2006, European urology.

[48]  C. Aragona,et al.  Rescue of spermatogenesis arrest in azoospermic men after long-term gonadotropin treatment. , 2006, Fertility and sterility.

[49]  A. Stemhagen,et al.  Prevalence of hypogonadism in males aged at least 45 years: the HIM study , 2006, International journal of clinical practice.

[50]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[51]  David Handelsman,et al.  Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis , 2006, The Lancet.

[52]  B. Zirkin,et al.  The Androgen Microenvironment of the Human Testis and Hormonal Control of Spermatogenesis , 2005, Annals of the New York Academy of Sciences.

[53]  C. Niederberger,et al.  Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. , 2005, Journal of andrology.

[54]  Z. Rosenwaks,et al.  Success of testicular sperm injection and intracytoplasmic sperm injection in men with klinefelter syndrome , 2005 .

[55]  C. Foresta,et al.  Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. , 2005, Fertility and sterility.

[56]  J. Gerss,et al.  Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. , 2005, European journal of endocrinology.

[57]  David Handelsman,et al.  Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens. , 2005, Human reproduction.

[58]  K. Herbst,et al.  Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. , 2005, The Journal of clinical endocrinology and metabolism.

[59]  A. Araujo,et al.  Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. , 2004, The Journal of clinical endocrinology and metabolism.

[60]  Ali Iranmanesh,et al.  Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. , 2004, The Journal of clinical endocrinology and metabolism.

[61]  G. Strain,et al.  Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. , 2003, Metabolism: clinical and experimental.

[62]  H. Burger,et al.  Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. , 2003, Journal of andrology.

[63]  D. Menon.  Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. , 2003, Fertility and sterility.

[64]  A. Agarwal,et al.  Oxidative stress and male infertility: from research bench to clinical practice. , 2002, Journal of andrology.

[65]  W. Crowley,et al.  Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. , 2002, The Journal of clinical endocrinology and metabolism.

[66]  V. Gebski,et al.  Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. , 2002, Human reproduction.

[67]  P. Schlegel,et al.  Aromatase inhibitors for male infertility. , 2002, The Journal of urology.

[68]  M. Goldstein,et al.  Evidence of a treatable endocrinopathy in infertile men. , 2001, The Journal of urology.

[69]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[70]  L. Plouffe,et al.  A pharmacological review of selective oestrogen receptor modulators. , 2000, Human reproduction update.

[71]  C. Raftopoulos,et al.  Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. , 1999, The Journal of clinical endocrinology and metabolism.

[72]  G. Gill,et al.  Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin. , 1998, Postgraduate medical journal.

[73]  J. Morley,et al.  Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. , 1997, The Journal of clinical endocrinology and metabolism.

[74]  A. Agarwal,et al.  Role of reactive oxygen species in male infertility. , 1996, Urology.

[75]  L. Lipshultz,et al.  The reversibility of anabolic steroid-induced azoospermia. , 1995, The Journal of urology.

[76]  R. Eaton,et al.  Impotence related to anabolic steroid use in a body builder. Response to clomiphene citrate. , 1995, The Western journal of medicine.

[77]  E. Nieschlag,et al.  High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. , 1994, European journal of endocrinology.

[78]  F. Flamigni,et al.  Dose‐dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study , 1992, Clinical endocrinology.

[79]  David Handelsman,et al.  Contraceptive efficacy of testosterone‐induced azoospermia in normal men , 1991 .

[80]  L. Lipshultz,et al.  Anabolic steroid-induced hypogonadotropic hypogonadism , 1990, The American journal of sports medicine.

[81]  D. Corle,et al.  Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. , 1988, Fertility and sterility.

[82]  W. Crowley,et al.  Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects. , 1986, Annals of internal medicine.

[83]  U. Krause,et al.  Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty. , 1985, Fertility and sterility.

[84]  Mohit Khera,et al.  Alternatives to Testosterone Therapy: A Review. , 2018, Sexual medicine reviews.

[85]  R. Ramasamy,et al.  Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial. , 2018, European urology focus.

[86]  E. Grober,et al.  Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters. , 2014, Fertility and sterility.

[87]  Ranjith Ramasamy,et al.  Words of wisdom. Re: Gonadal steroids and body composition, strength, and sexual function in men. , 2014, European urology.

[88]  U. Rai,et al.  Clomiphene citrate potentiates the adverse effects of estrogen on rat testis and down-regulates the expression of steroidogenic enzyme genes. , 2013, Fertility and sterility.

[89]  P. Stahl,et al.  Medical therapy for spermatogenic failure. , 2012, Asian journal of andrology.

[90]  E. V. van Beek,et al.  Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. , 2006, European heart journal.

[91]  R. Tan,et al.  Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse. , 2003, Fertility and sterility.

[92]  I. Cooke,et al.  A double blind trial of clomiphene citrate for the treatment of idiopathic male infertility , 1992 .